Friday wrap: in 2 words:deferred gratitude.
Ridiculous.
Tenth year anniversary of Cotara's1st approval to move into PIII FDA trials. We stand poised...
Where are the Chinese? Come on. Cotara has been approved in China for several years for lung cancer...anyone think it curious there are no positive peer-reviewed literature out of China on TNT MAB Cotara in lung cancer. No negative articles either. None. Hey, it doesn't work?! Who knows. A black hole Cotara fell into. Cotara is stalled. Communications are seriously lacking here.
Reacquainted myself with posts on this board (and others) during that 10 years. Definitely not a stockholder dream, PPHM stock, during that decade. Still aboard Ship PPHM. I've said for years Bavi will be approved in a close call, and not by acclaimation. Reality has settles in. Still hope. Lots and lots of people still not in on the secret of Bavi's briliant and prosperous future. Bavi must pay dues like all other modalities that have fought their way onto the cancer treatment table. The cancer victims lose mostly. Retail PPHM stockholders get an orgasmic price bump when all the money interests are aligned. Getting "shelf space" in any market is ferociously competitive no matter HOW good the product. Mainly I would love to be a fly on an executive suite wall at PPHM to hear some of the proceeds. But retail stockholders don't rate even a fly's worth of info. I'll hold-em. What else can I do. Can't sell. I'm trapped PPHM ... until payday.
